Castration-insensitive epithelial progenitors capable of regenerating the prostate are concentrated in the proximal region close to the urethra, but the identification of these cells has been limited to individual cell surface markers. Here, we use single cell RNA sequencing (scRNAseq) to obtain a cellular anatomy of the mouse prostate and urethra and create a comparative map with the human. These data reveal that previously identified facultative progenitors marked by TROP2, Sca-1, KRT4, and PSCA are actually luminal epithelia of the urethra that extend into the proximal prostate. These mouse urethral cells are the human equivalent of previously identified club and hillock urethral cells. Castration decreases androgen-dependent prostate luminal epithelia as expected, but TROP2+ urethral luminal epithelia survive and expand into the prostate. Benign prostatic hyperplasia (BPH) has long been considered an 'embryonic reawakening', but the cellular origin of peri-urethral growth is unclear. We use scRNA-seq and flow cytometry to demonstrate an increase in urethral luminal epithelia within glandular nodules from patients with BPH, which are further enriched in patients treated with a 5 alpha reductase inhibitor. These data demonstrate that the putative prostate progenitors enriched by castration in the proximal prostate are an expansion of urethral luminal epithelia and that these cells may play an important role in the etiology of human BPH.
inhibitor treatment in human BPH. These data suggest that luminal epithelia of the urethra are castration-insensitive cells of proximal ducts that may act as progenitors in human BPH.
Introduction
The mouse and human prostate develop as a series of solid epithelial buds from the primitive urethra, or urogenital sinus. Buds undergo a period of branching morphogenesis and canalization resulting in a tree-like network of proximal ducts and distal glands (1-3). We previously produced a cellular atlas of the young adult human prostate and prostatic urethra using single cell RNA sequencing (scRNA-seq) on proximal and distal anatomical regions. These data confirmed known cell types of the prostate such as basal, luminal, and neuroendocrine epithelia and led to the identification of previously unknown hillock and club epithelia as the major luminal epithelial cell types composing the prostatic urethra and its proximal ducts (4) . 'Intermediate' cells labeled with Keratin 19 , Keratin 8/18, and Keratin 5/14 are said to exist transiently in the adult and prior to prostate budding from the urogenital sinus during development (5, 6) . Prominent studies in other organs have shown that a rigorous mapping of equivalent mouse cell types with objectively defined cell type-specific markers can lead to better models of human disease (7, 8) , but a similar comparative cellular atlas of the human and mouse prostate has not been compiled.
The human prostate consists of a network of 12-14 paired proximal ducts located in the transition zone that empties secretory products of distal glandular units into the urethra (9) . Benign Prostatic Hyperplasia (BPH) is an expansion of the transition zone surrounding the urethra that occurs in a majority of aging men and is commonly treated with 5 alpha reductase inhibitors (5ARI) to cause apoptosis of androgen-dependent luminal epithelia (10, 11) . The cellular origin of periurethral prostate growth is unknown, but has been hypothesized to be an embryonic reawakening (12) (13) (14) (15) .
During development, multipotent basal epithelial progenitors give rise to basal, luminal, and neuroendocrine cell types (6, 16) . In the adult, basal and luminal lineages are unipotent (17) , but an 'intermediate' cell type with basal and luminal characteristics is said to give rise to luminal cells as well (6) . The prostate displays potent regenerative capacity after castration and subsequent androgen replenishment (18) , prompting the search for castration-insensitive prostate progenitors. Lineage tracing of luminal epithelia with Keratin 8 demonstrates that, after castration and regeneration, prostate luminal cells are largely derived from unipotent luminal progenitors (17, 19, 20) . Several studies have identified cell populations characterized by expression of BMI1 (21) , Sca-1 (22, 23) , TROP2 (24) , LY6D (25) , and KRT4 (26) that are enriched in the proximal region of the mouse prostate after castration, form spheroids at high frequency, and can act as facultative progenitors in prostate regeneration assays. A proximal to distal expansion of progenitors in human lineage tracing studies has also been demonstrated (27, 28) .
Proximal epithelia lineage traced with either basal (Keratin 5/14) or luminal (Keratin 8/18) markers or purified with individual cell surface markers show progenitor activity (22, (29) (30) (31) , but these transgenes and cell surface markers are expressed across multiple tissue types, making it difficult to precisely capture the identity of cell types of interest. These issues exemplify the need for objective transcriptional identities and cell surface markers of each cell type in the lower urinary tract.
Cell identity has historically been defined by individual markers, and the interpretation of data from experimental mouse models relies on these definitions. Here we perform scRNA-seq on the mouse prostate and urethra to build a comparative cellular atlas to the human in order to bolster the molecular and anatomical definition of each cell type (4, 32) . We use scRNA-seq, flow cytometry, and immunohistochemistry to demonstrate that the proximal castration-insensitive progenitor is a urethral luminal epithelial cell type that exists in the urogenital sinus before prostate budding and extends into the ductal network of the proximal prostate in the normal adult. Urethral luminal epithelia are increased in the proximal prostate of castrated mice as well as in human BPH patients treated with 5ARIs. When comparing the transcriptome of urethral luminal epithelia in normal young adults vs. BPH patients, a pronounced immunomodulatory phenotype is observed. In summary, our data demonstrate that luminal progenitors in the proximal prostate are actually an extension of castration-insensitive, immunomodulatory urethral luminal epithelia and that this cell type is resistant to 5ARI treatment in human BPH.
Results

Identification of equivalent epithelial cell types of the prostate and urethra in the mouse vs. human
We set out to identify equivalent human and mouse epithelial cell types in the prostate and urethra by scRNA-seq, given the essential role of the mouse in modeling human prostate disease. First, we combined ventral, dorsolateral, and anterior mouse prostate lobes for digestion and barcoding in aggregate. We also independently barcoded cells from the dissected urethra, which contains ejaculatory ducts and the epithelium of the prostatic urethra enclosed by the skeletal muscle of the rhabdosphincter. The data from the prostate and urethral regions were aggregated ( Figure S1A ) and equivalent cell types were identified by bioinformatical comparison to our previously published human prostate and urethra scRNA-seq dataset (4). After labeling major cell lineages (leukocytes, endothelia, fibromuscular stroma, and epithelia) in the mouse data using our previous human data ( Figure S1A , B), we sub-clustered the epithelia and displayed clusters split by anatomical region (Figure 1A, B ).
Mouse epithelial cell types were defined based on correlation to basal, luminal, and urethral epithelia in the human (4) and included one basal, two urethral, and three luminal clusters ( Figure 1C , Figure S1C , D). Given the enrichment of Pax2 in Wolffian duct derivatives (33), we labeled one of the urethral clusters as ejaculatory duct (ED). The three clusters of luminal epithelia corresponded to specific prostate lobes based on previous studies that identified lobe-specific expression of Msmb (dorsolateral, DLP), Tgm4 (anterior, AP), and Sbp (ventral, VP) (34) . Figure   1D demonstrates the enrichment of differentially expressed genes (DEGs) for each basal and luminal epithelial cluster. The full list of significant DEGs expressed in discrete cell types of the mouse prostate and urethra can be found in Dataset S1. Sequencing metrics for scRNA-seq on mouse prostate and urethra can be found in Dataset S2.
A novel mouse urethral luminal epithelial cell type was identified based on correlation to human club and hillock urethral cell types. Mouse urethral cells highly expressed Keratin 4 ( Figure   1D ) and were enriched in the urethra single cell preparation compared to the prostate ( Figure 1A , B). We were not able to identify a stereotypical club urethral epithelial cell type (characterized by expression of secretoglobins), in the mouse either in the scRNA-seq data or by immunostaining ( Figure S2 ). However, mouse urethral luminal cells share properties of both human club and hillock epithelia at the pan-transcriptomic level including expression of Psca ( Figure S2B ) (4) .
Urethral luminal epithelia extend into the proximal ducts of the prostate and express markers of prostate progenitor and intermediate cells
Proximal ducts of the mouse prostate have been shown to contain a concentration of androgen-independent progenitors (22, (29) (30) (31) , but identification and purification of these cells has relied on individual markers. To determine precisely where luminal epithelia of the urethra are located, we performed immunofluorescent staining on transverse whole mount sections with antibodies to KRT4 (urethral luminal), KRT5 (basal epithelia of urethra and prostate), and NKX3.1 (prostate luminal) (35) . We observed that luminal epithelia of the urethra and proximal ducts within and leading out of the rhabdosphincter are KRT4+/NKX3.1-and transition immediately into KRT4-/NKX3.1+ prostate epithelial cells ( Figure 2A ). The transition from urethral identity to prostate identity in human proximal ducts can be similarly highlighted using KRT13 (urethral luminal cell) and ACPP (prostate luminal cell) ( Figure 2B ). Similar to our previous human prostate study, neuroendocrine epithelia are an extremely rare cell type that do not cluster independently, but can be identified using known markers such as CGRP and CHGA ( Figure S3A According to previous studies, epithelia that are enriched in facultative stem cell assays display markers such as BMI1 (21), Sca-1 (22, 23) , TROP2 (24), LY6D (25) , and KRT4 (26) . A dot plot of putative stem cell markers demonstrates that these markers are almost exclusively expressed by the urethral luminal epithelial cluster, although some proposed stem cell markers such as CD133 (Prom1) are enriched in luminal epithelia of the ejaculatory ducts ( Figure 2C ).
Krt19 has historically been associated with KRT5+/KRT8+ 'intermediate' cells transitioning from basal to luminal (5), but is highly enriched in urethral luminal epithelia. CD49f and Sca-1 are commonly used to isolate prostate basal (CD49f hi /Sca-1 hi ) and luminal (CD49f lo /Sca-1 lo ) epithelia (24, 26, 31) . Multiple studies have also identified a progenitor 'LSC med ' population (CD49f med /Sca-1 hi ) enriched in castration and tumorigenesis (22, 26) . Correlation analysis of transcriptomic signatures from cells in each of these three flow cytometry gates from Sackmann Sala et al. (26) versus each of our scRNA-seq epithelial clusters demonstrates that the urethral luminal epithelia cluster is highly similar to the LSC med androgen-independent luminal progenitor ( Figure 2D ).
These data suggest that the full identity of the luminal prostate progenitor that is increased in castration and prostate tumors is actually the urethral luminal cell.
TROP2+ urethral luminal epithelia are enriched in castration
Given the transcriptional similarity of urethral luminal epithelia to facultative progenitors ( Figure 2D ), we set out to quantitate the frequency of urethral luminal epithelia in discrete anatomical regions of an intact mouse. We dissected the urethra (UR) away from proximal and distal prostate regions for digestion into single cells ( Figure 3A ) and developed a flow cytometry scheme using TROP2 (Tacstd2) as a cell surface marker, given its selectivity for urethral luminal epithelia over Sca-1 (Ly6a/e) in the scRNA-seq data ( Figure 2C ). However, TROP2 and Sca-1 label a largely overlapping population of cells (data not shown).
Our gating scheme first separates leukocytes (CD45+), epithelia (CD326+), and stroma (CD45-/CD326-). CD326+ epithelia are then gated into prostate luminal (CD26+) and non-prostate luminal (CD26-) cells. Previously used cell surface markers such as CD24 (Cd24a) label prostate luminal epithelia (22) , but also luminal epithelia of the ejaculatory ducts and urethra, whereas CD26 (Dpp4) is selectively enriched in prostate luminal epithelia ( Figure 2C ). CD26+ prostate luminal epithelia are enriched in the proximal and distal prostate (42.1 ± 4.8% and 40.1 ± 4.4% of total epithelia, respectively) compared to the urethra (12.5 ± 2.1% of total epithelia).
Because basal epithelia can also be positive for TROP2, urethral luminal epithelia are more accurately identified in the PDPN-/CD26-(non-basal, non-prostate luminal) gate. TROP2+ urethral luminal cells represent 20.6 ± 1.6% of total epithelia within the urethral region, and 0.44 ± 0.10% of total epithelia within the proximal prostate, compared to 0.22 ± 0.05% in the distal prostate (from 4 independent experiments) ( Figure 3B ). Figure S4 demonstrates that KRT4 and TROP2 identify the same cell type by displaying overlapping expression in the mouse urethra and proximal prostatic ducts.
Proximal KRT4+/Sca-1+/NKX3.1-prostate progenitors have been shown to be enriched after castration as well as in tumorigenesis (23, 26, 31) . To determine whether TROP2+ urethral luminal epithelia are likewise enriched after castration, we used our optimized flow cytometry antibody panel to quantitate epithelial cell types in castrated vs. sham castrated mice. TROP2+ urethral luminal epithelia are increased in prostates from castrated mice (11.9% of total epithelia) compared to sham castrated mice (1.33% of total epithelia) animals, while CD26+ prostate luminal epithelia represent 26% of total epithelia in sham mice compared to 18% in castrated mice ( Figure   3C ). These data are highly similar to the 4-fold increase in Sca-1+/CD49f med luminal epithelia ('LSC med ') after castration in a previous study and the transcriptomic signature of this population was highly correlated with our urethral luminal signature ( Figure 2D ), further suggesting these are the same cell type (26) . We demonstrate in situ that the increased percentage of TROP2+ urethral luminal epithelia after castration is due to survival and expansion into the prostate using a TROP2 antibody in sham and castrate whole mount lower urinary tracts ( Figure 3D , E).
Urethral identity is established prior to prostate budding in mouse and human
The prostate goes through a developmental process of bud initiation, branching morphogenesis, and canalization (1, 2). Although several adult epithelial cell populations can act as facultative progenitors in tissue regeneration and spheroid assays (17, 36) , lineage tracing analyses suggest that the basal and luminal lineages are largely unipotent in the adult (6, 17) .
However, the transgenes used in these studies (Krt5 and Krt8) label basal and luminal epithelial cells from prostate, urethra, and ejaculatory ducts, highlighting the need for developing tissuespecific markers and understanding when and where they are expressed during development.
To determine whether the identity of urethral epithelia is established early in the developmental process, we examined developmental stages of the mouse and human prostate.
Mouse urethral luminal epithelia could be identified by KRT4 during the earliest stages of bud initiation (E18.5) where these cells occupied the inner region of prostate buds. During the branching stage (P9), KRT4+ urethral luminal cells were present in the urethra and branching prostate ducts ( Figure 4A , B) (1, 2). In the adult mouse prostate, KRT4+ urethral cells were restricted to the urethra and urethra-proximal ductal segments ( Figure 4C ). In the human male, prostate buds initiate at 10-13 weeks and undergo branching morphogenesis beginning at 12-18 weeks (37) . At 12 weeks gestation, club and hillock cells marked by SCGB1A1 and KRT13, respectively, could be observed in the urethra and developing buds ( Figure 4D ). At 19 weeks gestation, club and hillock luminal epithelia could be observed in the urethra and in proximal segments of branching prostatic ducts ( Figure 4E ). In the adult human male, club and hillock urethral luminal epithelia extend into the proximal ductal network as shown in the sagittal plane ( Figure 4F ). These results demonstrate that the identity of urethral cell types is established before prostate budding and branching morphogenesis, which could have implications for human BPH if it is indeed a reawakening of embryonic processes. Replicates for each stain on independent specimens can be found at https://doi.org/10.25548/16-WM8C .
Urethral epithelial cells are increased in human BPH and are resistant to 5ARI treatment
Benign prostatic hyperplasia (BPH) is a continuous expansion of the prostate transition zone that affects 70% of men over 70 years old and has been hypothesized to be a reawakening of developmental processes (14, 15) . To identify cell types present in BPH, we performed scRNAseq on glandular nodules from three patients who underwent simple prostatectomy for lower urinary tract symptoms (see Dataset S2 for sequencing metrics and Dataset S3 for clinical data on each patient) and sub-clustered the epithelia for comparison to three young normal prostates (4) ( Figure 5A ). The results demonstrate an increase in club urethral luminal epithelia from 2% of epithelia in the normal prostate to 9% of epithelia within glandular BPH. We previously established PSCA as a highly specific cell surface marker capable of capturing a 94% pure population of prostatic urethral luminal epithelia in the human (4). To confirm whether PSCA+ urethral luminal epithelia are increased in glandular BPH in a larger cohort, we performed flow cytometry on nondiseased prostates from young organ donors (n=6) for comparison to glandular BPH specimens from men (n=6) undergoing simple prostatectomy (Dataset S3, Figure S5 ). PSCA+ urethral luminal epithelia are significantly increased in glandular BPH compared to young donor prostates ( Figure 5B ). With the aggregation of normal and BPH scRNA-seq data, we generated cell typespecific DEGs to get a basic understanding of the functional contributions of each cell type in disease. Dataset S5 displays the significant DEGs for each epithelial cell type in normal vs. BPH.
To annotate the functional changes in club cells in BPH vs. normal human prostate, we performed a KEGG analysis (38) of DEGs in BPH clubs cells compared to normal club cells. In the normal adult human, urethral luminal epithelia are highly enriched in metabolic pathways (4) , which is the same for the mouse (data not shown). However, Figure 5C shows that the majority of the genes that are significantly upregulated in club cells from BPH tissue belong to immunomodulatory pathways.
Five alpha reductase inhibitors (5ARIs) are widely used to treat BPH patients. 5ARI treatment shrinks prostate volume through luminal cell apoptosis by inhibiting the conversion of testosterone to dihydrotestosterone (DHT) (10) . Given that castration in the mouse enriched for TROP2+/KRT4+ urethral luminal epithelia ( Figure 3C -E), we set out to test whether urethral epithelial cells were increased in areas of atrophy within human BPH in patients treated with a 5ARI. Accordingly, we performed dual immunohistochemistry for club (SCGB1A1) and hillock (KRT13) urethral luminal epithelia in young men and in men with BPH that were not taking a 5ARI.
We could detect rare SCGB1A1+ club cells in 5ARI-naïve men with BPH similar to the scRNAseq data ( Figure 5D , E). However, analysis of whole mounted prostates from 11 different 5ARItreated men revealed a striking increase in the number of club and hillock epithelia in focal areas of atrophy, further suggesting DHT independence of urethral luminal epithelia in areas of prostate luminal cell apoptosis ( Figure 5F , Dataset S3). Replicates for each stain on independent specimens can be found at https://doi.org/10.25548/16-WM8C.
Discussion
We have produced a cellular anatomy of the mouse prostate and urethra, by comparing the molecular identity of equivalent cell types and their locations to the human (Figures 1 and 2 ). We demonstrate that many of the markers previously used to characterize castration-insensitive prostate progenitors (20, 22-26, 29-31, 39-43) are highly expressed by urethral luminal epithelia, suggesting that the facultative progenitors of the proximal prostate described as NKX3.1-luminal epithelia are of urethral origin ( Figure 2C ). Moreover, similar to the human anatomy, mouse urethral luminal epithelia extend into the proximal ducts of the prostate before transitioning to prostate epithelial identity (Figure 2A, B) , which explains why NKX3.1-/Sca-1+/TROP2+ cells are enriched in the proximal prostate (22, 24, 31) .
The characterization of prostate epithelial cells that survive castration and serve as cells of origin for regeneration has been reviewed extensively and has important implications for prostate disease (44) . Lineage tracing experiments demonstrate that multipotent basal epithelia give rise to basal, luminal, and neuroendocrine epithelia during prostate organogenesis (6, 16) .
In the homeostatic adult mouse, basal and luminal epithelia are largely maintained by unipotent progenitors (17, 36) . Under castrate conditions, the prostate regresses due to the loss of luminal epithelia, but can be re-grown to its original size with androgen re-administration (18, 29) . Select enrichment of castration-insensitive subpopulations characterized by expression of NKX3.1 (20) ,
LGR5 (41), BMI1 (21), Sca-1 (22, 31) , TROP2 (24), CD133 (23), LY6D (25) , and KRT4 (26) have been described using lineage tracing, flow cytometry, and facultative regeneration assays. Label retention by slow cycling cells after multiple rounds of castration has also been proposed as a characteristic of stemness, and a transcriptional profile of labeled cells demonstrates survival of a luminal cell population after androgen deprivation (43) . Castration-insensitive luminal epithelia that display many of these individual characteristics are shown to be enriched in the proximal region of the prostate, but defining a cell type as prostate based on 'luminal' (e.g. KRT8/18 expression) characteristics and anatomical location does not take into account the many different types of luminal cells that exist in this complex region where the prostate, ejaculatory ducts, and urethra merge. This is especially important to take into account when indelibly labeling KRT8+ cells with a fluorophore prior to prostate budding, where even the urogenital sinus epithelia marked by expression of KRT4 ( Figure 4 ) also express KRT8 (6) . Through scRNA-seq, we have been able to specifically identify a KRT8+ luminal cell type of the urethra that is the castrationinsensitive progenitor of the proximal prostate described in previous studies (20, 22-26, 29-31, 39-43) .
Single cell RNA sequencing provides an objective identification of cell types based on the expression of a wide range of transcripts. We previously used scRNA-seq to produce a cellular anatomy of the normal adult human prostate and prostatic urethra, revealing the existence of two novel urethral luminal epithelial cell types (club and hillock) that extend into the proximal ductal network that connects distal prostate glands to the prostatic urethra (4). In our own dissections of the mouse prostate lobes away from the urethra, we observe that 0.44 ± 0.10% of the total epithelia in the homeostatic proximal prostate are TROP2+ urethral luminal cells ( Figure 3B) , and that these cells are highly enriched in prostates from castrated mice ( Figure 3C, D) . Comparing the transcriptomic signature of Sca-1+ cells enriched in castration from a separate study (26) revealed high correlation with our urethral luminal epithelia ( Figure 2D ), suggesting that these are the same cell type. These data suggest that dissections of prostate lobes include extensions of the urethra into the proximal ductal network.
The incidence of benign and malignant prostate disease in proximal (transition/central zones) and distal (peripheral zone) anatomical regions, respectively, has long perplexed prostate biologists (9, 45) . It has been proposed that BPH is a reawakening of morphogenic activity by prostate stem cells (13, 15) , but the full identity of cell types that propagate prostate growth has been elusive. Given the dramatic increase in urethral epithelial cells in the prostates of 5ARItreated men ( Figure 5 ), it is tempting to postulate that BPH is a process of budding and branching of the urethra and that 5ARI treatment is 'trimming the leaves', but 3-dimensional reconstructions of the prostate ductal architecture will be necessary for confirmation. As possible evidence that BPH is a reawakening of urethral budding and branching, we demonstrate that the identity of urethral luminal epithelia is established prior to prostate budding in the developing mouse and human ( Figure 4 ). Evidence from lineage tracing studies of mitochondrial mutations in humans demonstrates a clonal expansion of cells in the proximal urethra to the distal prostate in healthy adults (27, 28) , but needs confirmation in BPH specimens.
Identification of urethral luminal cells as the castration-insensitive progenitor enriched in
facultative stem cell assays could be interpreted in multiple ways. It is possible that the fetal mesenchyme used in facultative regeneration assays used to assess stemness is unnaturally inductive, as historical studies have shown that even adult bladder or urethral epithelium can be transdifferentiated to prostate (39, 46, 47) . Moreover, spheroid and label-retaining assays might enrich multiple cell types that cycle relatively slower or survive better under certain ex vivo conditions than other cell types. Alternatively, urethral luminal epithelia (or even ejaculatory duct luminal epithelia, which express high levels of the putative stem cell marker CD133 (40)) are actually progenitors for the prostate under stressed conditions such as castration, inflammation, and cancer. These possibilities need to be assessed with tissue-and cell type-specific lineage tracing models.
Finally, it will be important to characterize the functional role of urethral luminal epithelial cells in maintaining the health of the prostate. Club and hillock epithelia of the lung are antiinflammatory, anti-bacterial, and anti-viral and can also serve as progenitors in certain situations (8, 48, 49) . The transcriptomic signature of urethral epithelia in the human and mouse prostate also suggests progenitor and immunomodulatory activity, suggesting the potential for a similar functional role in protecting distal prostate tissue from environmental exposures and infections ( Figure 5C ). The increased abundance of urethral epithelia within glandular nodules in BPH patients could simply indicate an expansion in response to infection or inflammation. Alternatively, these cells could be acting as progenitors that differentiate into prostate and contribute to growth due either to intrinsic properties of stemness or extrinsic signaling from the surrounding stroma (42) . 
Methods
Contact for reagent and resource sharing. Further information and requests for resources and
reagents should be directed to and will be fulfilled by the Lead Contact, Douglas Strand (Douglas.Strand@UTSouthwestern.edu), following MTA approval.
Human subjects. Healthy prostate specimens used in this study were obtained from 15, year old male organ donors whose families were consented at the Southwest Transplant Alliance Mouse tissue collection and castration. Male C57Bl/J mice were obtained from the UT Southwestern Mouse Breeding core. Lower urinary tract tissues were collected from mice after euthanasia. Eleven week old mice were subjected to castration surgery following approved surgery protocols. The prostate was allowed to involute for 2 weeks before the mice were euthanized for tissue collection. Single cell sequencing data analysis. Data analysis was based on previously published analysis (4, 50) , modified in the following ways:
Cellranger. Cellranger mkfastq and count (version 3.1.0) was used to demultiplex, combine sequencing runs on the same sample, and to call cells. The reference genomes used were GRCh38 and mm10 (10x Genomics version 3.0.0). These 10x Genomics tools were automated and parallelized using the UT Southwestern Bioinformatics Core Facility (BICF) pipelines (51, 52) .
Cell filtering. Low quality cells were filtered out by consecutively filtering each sample individually based on UMI counts, percentage mitochondrial content (%mito), and number of genes (in that order). Filter thresholds were chosen dynamically for samples based on the distribution of the parameter. The upper bound of the UMI filter was determined by removing cells with UMI counts lower than the highest frequency bin (10 bins) and scaling the remaining cells' UMI between 0 and 360 and applying the RenyiEntropy thresholding technique. The lower bound of the UMI filter was set to 200. The bounds to the %mito and gene number filters were determined similarly. High %mito threshold was determined using the Triangle filter on the rescaled (0-360) parameter, from cells with a greater than or equal value to the highest frequency binned %mito (100 bins). The lower bound to the gene count filer was determined using the MinErrorI filter on the rescaled (0-360) parameter, from cells with less than the value to the highest frequency binned gene count (100 bins). Cells were not filtered for low %mito or high %gene count. RenyiEntropy, Triangular, and MinErrorI thresholding was applied using autothresholdr version 1.3.5 (53) . Human to mouse cell type transfer. Mouse cell types were identified similarly as the human. Broad cell lineages were identified using the main labels from the built-in mouse Immunological Genome Project data (60) . The cell types were merged as with the human data. Epithelial cells were subset, and re-clustered (as above). Prostate epithelial cell types were labeled using the identified data from the human samples, with the genes converted to mouse orthologs (genes with no orthology were removed) in cluster mode, at a resolution of 0. expression their expression of G2M and S phase genes (63) . Low quality cells and multiplets were excluded by removing cells with fewer than 500 unique genes and greater than 3,000 unique genes, as well as cells with greater than 10% of their transcriptome being mitochondrial genes.
Data was then scaled to 10,000 and log transformed. Mitochondrial genes were then removed from further analysis. UMI counts were then scaled and variation due to differences in UMI/cell, percent mitochondrial genes, and cell cycle phase were regressed out of the data using a built-in Seurat function. Cells from the three patients were then subsetted and recombined using canonical correlation analysis (CCA) in order to align the clusters. The highest variable genes were found with an algorithm developed by Macosko et al (64) , and were defined as an average expression between 0.2 and 5 with a dispersion greater than 1. The intersection of these genes between the three patients were used to calculate 50 CCAs and the first 30 were aligned. These 30 aligned-CCAs were used for t-SNE visualization and clustering. Cells were clustered using a graph-based clustering approach (55) . Briefly, cells were embedded in a KNN graph structure based on their Euclidean distance in PC space, with edge weights refined by shared overlap in their Jaccard distance. Different resolutions were generated based on a granularity input. Dataset S1 (separate file). Differentially expressed genes for each mouse cluster.
Dataset S2 (separate file). Single cell RNA sequencing metrics for each specimen.
Dataset S3 (separate file). Clinical data for each human specimen.
Dataset S4 (separate file). Antibody information for flow cytometry and immunostaining.
Dataset S5 (separate file). Differentially expressed genes for each human prostate and urethral epithelial cell type in normal vs. BPH.
